TITLE

QALY - Measure of Cost-Benefit Analysis of Health Interventions

AUTHOR(S)
Višnjić, Aleksandar; Veličković, Vladica; Milosavljević, Nataša Šelmić
PUB. DATE
December 2011
SOURCE
Acta Facultatis Medicae Naissensis;Dec2011, Vol. 28 Issue 4, p195
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
For the purpose of economic evaluation in the health economics, several analytical techniques that are designed for comparing two or more health interventions in terms of costs and effects are used. Cost-benefit analysis provides the opportunity of comparing values of alternative health interventions that have very different health benefits, which significantly facilitates comparisons. The purpose is to assess the relationship between the cost and utility of health interventions in terms of the patient's number of years in full health. The most commonly used measure in these analyses is QALY (Quality-adjusted life-year). QALY is a measure of the impact of health interventions and treatment that combines two dimensions of health outcomes: the degree of health improvement and the time period for which the improvement of health is exhibited, including the length of life. Determining the QALY is one of the most effective ways of decision-making about distribution of resources in the health care system. The method is designed to distribute resources in such a way as to be spent where they will bring the maximum possible benefit for the patient. If we have to make decisions how to direct funds from limited budgets, then each and the lowest cost has to correlate to the maximum possible benefit and these methods are the best tool under such conditions.
ACCESSION #
74294021

 

Related Articles

  • Avoiding breaks with bisphosphonates is cost effective.  // PharmacoEconomics & Outcomes News;12/12/2009, Issue 593, p5 

    The article focuses on a study which estimated the costs and outcomes associated with oral biphosphonates. The study calculated the costs and outcomes associated three scenarios for oral bisphosphonates, including no treatment, real-world adherence and full adherence. It found that real-world...

  • Is the QALY blind, deaf and dumb to equity? NICE's considerations over equity. Soares, M. O. // British Medical Bulletin;Mar2012, Vol. 101 Issue 1, p17 

    Introduction/background The quality-adjusted life year (QALY) is the preferred measure of health outcome used to inform decisions over the use of health care interventions in the UK NHS. This measure considers the overall impact of alternative interventions on both the quantity and quality of...

  • Is The United States Ready For QALYs? Neumann, Peter J.; Greenberg, Dan // Health Affairs;Sep/Oct2009, Vol. 28 Issue 5, p1366 

    Quality-adjusted life-years (QALYs) are used in cost-effectiveness analyses to aid coverage and reimbursement decisions worldwide. QALYs provide a flexible and convenient metric for measuring and comparing health outcomes across diverse diseases and treatments. But their use has stirred...

  • Determining risk preferences for pain. Kroll, Eike B.; Trarbach, Judith N.; Vogt, Bodo // NeuroPsychoEconomics Conference Proceedings;2011, p25 

    The QALY concept is the commonly used approach in research to evaluate the efficiency of therapies in cost utility analysis. We investigate the risk neutrality assumption for time of the QALY concept: can time be included as a linear factor? Various studies show that this assumption does not...

  • Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments. Nikfar, Shekoufeh; Kebriaeezadeh, Abbas; Dinarvand, Rassoul; Abdollahi, Mohammad; Sahraian, Mohammad-Ali; Henry, David; Akbari Sari, Ali // DARU; 

    Background: Multiple sclerosis (MS) is a highly debilitating immune mediated disorder and the second most common cause of neurological disability in young and middle-aged adults. Iran is amongst high MS prevalence countries (50/100,000). Economic burden of MS is a topic of important deliberation...

  • The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. Bobinac, Ana; Exel, Job; Rutten, Frans; Brouwer, Werner // PharmacoEconomics;Jan2014, Vol. 32 Issue 1, p75 

    Background: There is an increased interest in the monetary value of a quality-adjusted life-year (QALY). Past studies commonly derived willingness to pay (WTP) for certain future QALY gains. However, obtaining valid WTP per QALY estimates proved to be difficult. Objective: We conducted a...

  • Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis. Ikechukwu Ekwunife, Obinna; Okafor, Charles E.; Ezenduka, Charles C.; Udeogaranya, Patrick O. // Cost Effectiveness & Resource Allocation;2013, Vol. 11 Issue 1, p2 

    Background: Many drugs are available for control of hypertension and its sequels in Nigeria but some are not affordable for majority of the populace. This serious pharmacoeconomic question has to be answered by the nation's health economists. The objective of this study was to evaluate the...

  • The 'how' and 'why' of cost-effectiveness analysis for care pathways. Broughton, Edward I. // International Journal of Care Pathways;Sep2011, Vol. 15 Issue 3, p76 

    Health service improvement interventions such as care pathways should be evaluated for cost-effectiveness the same way other health interventions are. I describe what cost-effectiveness analyses (CEAs) for care pathways are, how they are conducted and how their results are interpreted. CEAs...

  • Favourable cost-benefit in an early defibrillation programme using dual dispatch of ambulance and fire services in out-of-hospital cardiac arrest. Sund, Björn; Svensson, Leif; Rosenqvist, Mårten; Hollenberg, Jacob // European Journal of Health Economics;Dec2012, Vol. 13 Issue 6, p811 

    Aims: Out-of-hospital cardiac arrest is fatal without treatment, and time to defibrillation is an extremely important factor in relation to survival. We performed a cost-benefit analysis of dual dispatch defibrillation by ambulance and fire services in the County of Stockholm, Sweden. Methods...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics